Clinical Trial Update: A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omalizumab to prevent bronchoconstriction after cat dander exposure in patients with cat dander-induced asthma; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2013-03-27